Clinical Trial Update: Study of Aripiprazole to Treat Children and Adolescents With Autism [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating aripiprazole in children and adolescents with autism spectrum disorders has completed, with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asperger Syndrome
• Autism Spectrum Disorder

Drugs mentioned

• Abilify (aripiprazole)

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Autistic Disorder, Asperger Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2014-03-26